SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-023097
Filing Date
2024-02-05
Accepted
2024-02-02 21:39:30
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d739939ds3.htm S-3 212572
2 EX-5.1 d739939dex51.htm EX-5.1 11053
3 EX-23.1 d739939dex231.htm EX-23.1 2159
4 EX-23.2 d739939dex232.htm EX-23.2 1647
5 EX-23.3 d739939dex233.htm EX-23.3 1814
6 EX-FILING FEES d739939dexfilingfees.htm EX-FILING FEES 13981
7 GRAPHIC g739939g0202034227491.jpg GRAPHIC 1653
8 GRAPHIC g739939g40q28.jpg GRAPHIC 38011
  Complete submission text file 0001193125-24-023097.txt   299384
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276856 | Film No.: 24593715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)